Google.org

Overture Life, Inc. is a biotechnology company established in 2017 and headquartered in New York, New York. The company specializes in developing robotic technology and medical devices aimed at automating the in vitro fertilization (IVF) process. Overture Life's innovations include novel embryo testing methodologies and automated cryopreservation services, which help fertility clinics identify viable embryos prior to implantation. By streamlining the IVF process, Overture Life aims to make artificial insemination more accessible, reduce costs, optimize resource use, and improve success rates for practitioners and patients alike.

UJET, Inc. specializes in developing customer support software and platform solutions that enhance customer communications. Founded in 2015 and headquartered in San Francisco, with additional offices in New York and Seoul, the company offers a cloud contact center platform that integrates seamlessly with major customer relationship management systems like Salesforce, Zendesk, and Kustomer. UJET's platform is designed for the smartphone era, modernizing digital and in-app customer experiences while eliminating the need for customers to switch between different communication channels. By utilizing multiple voices, online messaging, and mobile features, UJET assists customer service agents in managing incoming calls and resolving issues efficiently. The incorporation of artificial intelligence across its services further automates processes and improves interaction quality. Additionally, UJET provides a wait time messaging tool that offers live updates to customers while they are on hold, enhancing overall service satisfaction.

Cardurion Pharmaceuticals, LLC is a biotechnology company based in Boston, Massachusetts, established in 2017. The company specializes in developing innovative therapeutics aimed at treating heart failure and other cardiovascular diseases. Cardurion is advancing clinical programs that focus on inhibiting PDE9 and CaMKII, utilizing its knowledge of cardiovascular signaling pathways to meet significant patient needs in this area.

Solstice is a company dedicated to making renewable energy accessible to all Americans through community-shared solar power. Founded in 2016 and headquartered in Cambridge, Massachusetts, Solstice provides comprehensive customer solutions for shared solar, including subscriber aggregation and management services aimed at solar developers, utilities, and other providers. By employing community organizing techniques along with its innovative online marketplace, Solstice aggregates consumer demand to facilitate the deployment of community solar projects. This approach enables renters and homeowners with non-optimal roofs to participate in solar energy, allowing them to save on utility bills without upfront costs. Solstice is driven by a commitment to energy equity, striving to ensure that affordable renewable energy is available to every household, regardless of income or credit status. The company has been recognized with multiple awards for its contributions to clean energy and entrepreneurship.

If a technical career is what you seek, Benjamin Franklin Institute of Technology (BFIT) provides you with the education you need to pursue your professional goals. For over a century, BFIT has been one of Boston’s top career colleges. The institute has helped students reach their potential through technical education programs in the following types of fields: * Automotive Technology * Computer Technologies * Electronics Engineering Technology * Mechanical Engineering Technology * Medical Electronics Engineering Technology * Ophthalmic Assisting The Academic Success Center at BFIT ensures that students are given the resources and tools they need to excel in their academics and training. Some of the services offered through the center include: academic advising, special accommodations, tutoring, and more. College life at BFIT is filled with exciting experiences. From dorm life and council leadership to community service and intramural sports, the school encourages students to get involved in extracurricular activities. Applicants who are interested in admissions to the school must submit Accuplacer test results, an application, recommendation letters, and official transcripts for review. The school will waive its enrollment fee for any admissions applications submitted online. Merit and need-based financial aid exists in many forms at BFIT for those who qualify and are looking for tuition assistance.

Delphia Therapeutics, headquartered in Boston, USA, is a biotechnology company focused on developing innovative cancer treatments. It operates a laboratory where researchers study cancer-driving pathways to create targeted therapies. The company's approach involves selectively over-activating certain cancer-linked cell signaling pathways, making tumor cells unsustainable and enabling more effective cancer treatment for patients.

Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom, the company utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, using a repository of over 15,000 human brain tissue samples. This platform provides detailed expression and epigenetic data, allowing Cerevance to identify promising therapeutic targets for central nervous system diseases. Through its research, the company aims to advance new medicines that can potentially address the underlying mechanisms of these debilitating conditions.

Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.

Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.

Oort is a decentralized data cloud platform focused on enhancing privacy and cost efficiency by harnessing global computing and storage resources. The company provides enterprise-grade cloud solutions tailored for generative AI and data-driven businesses. As a pioneer in intelligent decentralized data cloud technology, Oort is supported by U.S. patents and academic research. With a strong network of partnerships, Oort collaborates with over 40 projects and companies, including notable names such as DELL, Tencent Cloud, and Cardano, and has established connections with prestigious institutions like Harvard, MIT, and the University of Chicago. Headquartered in New York, Oort's core team comprises professionals from esteemed organizations such as Columbia University, Qualcomm, AT&T, and JP Morgan. The platform also employs blockchain technology to enable metaverse developers to access decentralized computing power, offering a scalable solution for web3-native products.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, the company utilizes the repeatome—a previously overlooked segment of genetic material—to create novel treatment options. By identifying multiple drug targets and advancing several discovery programs, ROME Therapeutics aims to tap into this unexplored area of biology. The organization has assembled a team of experts in oncology, immunology, virology, and machine learning to lead its research and development efforts, which are designed to provide healthcare professionals with effective new treatments for patients suffering from these conditions.

Nimbus Therapeutics, based in Cambridge, Massachusetts, is a biotechnology company focused on discovering and developing innovative medicines for serious diseases, including metabolic disorders, cancer, and immune-inflammatory conditions. The company utilizes advanced computational technologies to create selective and potent small-molecule therapeutics. Among its notable projects is the Nimbus Apollo program, which features the lead candidate NDI-010976, an allosteric inhibitor targeting Acetyl-CoA Carboxylase (ACC). This compound is being developed for the treatment of non-alcoholic steatohepatitis (NASH) and has potential applications in hepatocellular carcinoma (HCC) and other diseases. NDI-010976 received Fast Track designation from the U.S. Food and Drug Administration in 2016, highlighting its significance in the clinical development pipeline. Nimbus Therapeutics has formed strategic partnerships to enhance its research and development capabilities, reinforcing its commitment to advancing treatment options for complex health challenges.

Hugging Face, established in 2016 and based in New York, specializes in open-source machine learning technologies. It operates a platform that facilitates collaboration on machine learning projects, including models, datasets, and applications. The company aims to democratize machine learning by providing tools and services that support and advance the field, while also offering paid computing and enterprise systems to accelerate development.

Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

Superplastic, Inc. is a character-based product and entertainment company founded in 2017 and based in Burlington, Vermont. The company specializes in manufacturing and marketing limited edition art toys, apparel, games, and animation, featuring unique characters created in collaboration with renowned artists. Superplastic leverages the principles of effort and scarcity to enhance the value of its offerings, creating exclusive works of art for a select audience. The company also operates a platform that engages customers through various media, including animated videos and music, enabling interactions with its synthetic superstars in innovative ways. Products are primarily sold online, reflecting a modern approach to retail and entertainment.

Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom, the company utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, using a repository of over 15,000 human brain tissue samples. This platform provides detailed expression and epigenetic data, allowing Cerevance to identify promising therapeutic targets for central nervous system diseases. Through its research, the company aims to advance new medicines that can potentially address the underlying mechanisms of these debilitating conditions.

Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.

Galileo, Inc. is a technology company that specializes in providing healthcare solutions through a mobile application, enabling direct access to clinical care and expertise via smartphones. Founded in 2014 and headquartered in New York, the company facilitates communication between healthcare providers and patients using advanced telecommunications technologies. Galileo delivers high-touch, data-driven, multi-specialty care to a diverse patient population, offering services over the phone and in various settings. The company is recognized by regional and national health plans, employers, and major corporations for its effectiveness in enhancing population health. Galileo's mission is to address complex healthcare challenges and foster closer connections between patients and providers.

Landis is an online real estate platform founded in 2018 and headquartered in New York, NY, that focuses on helping renters become homeowners. The company allows clients to choose their dream home, rent it, and purchase it within the first twelve months. In addition to facilitating this transition, Landis provides tools and incentives designed to assist clients in improving their credit scores and accumulating down payment savings. With a commitment to transparency and simplicity, Landis aims to create a seamless process for renters to transition to homeownership. The company also specializes in commercial real estate technology and residential offerings.

Fractyl Health, based in Lexington, Massachusetts, specializes in developing innovative medical device solutions for metabolic diseases, particularly type 2 diabetes and obesity. The company’s primary offering, Revita DMR, is a minimally invasive therapy that utilizes hydrothermal ablation to rejuvenate the duodenal lining, which can become compromised due to high-fat and high-sugar diets. By focusing on durable disease-modifying therapies rather than just symptomatic management, Fractyl Health aims to address the underlying causes of metabolic diseases, improving patient outcomes and reducing healthcare burdens. Founded in 2010 and originally named MedCatalyst, Inc., the company envisions a future where less invasive, device-based therapies provide effective solutions for large populations affected by metabolic disorders.

Merlin Labs is an innovative company focused on creating autonomous flight technology for advanced air travel, primarily utilizing fixed-wing aircraft. Founded in 2018 and headquartered in Boston, Massachusetts, the company develops a sophisticated aircraft autonomy system that employs artificial intelligence and machine learning, akin to the technology used in driverless cars. This system aims to facilitate the pilotless transportation of goods and eventually people, establishing a new infrastructure for aerial mobility.

Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.

SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics, catering to global enterprises. Founded in 2011 and headquartered in San Francisco, California, the company offers the SingleStore Managed Service, a cloud database-as-a-service that enables analytics on various cloud platforms, alongside SingleStore DB, a distributed SQL database suitable for both bare metal and hybrid cloud environments. The company focuses on operational analytics and supports modern data platform solutions that encompass IoT analytics, risk management, and customer engagement. SingleStore serves a diverse range of industries, including financial services, media communications, energy and utilities, government, and retail. The company, previously known as MemSQL Inc., rebranded to SingleStore, Inc. in October 2020 and also maintains offices in Seattle, Boston, Portland, Lisbon, and London.

FYTO, Inc. is a company based in Cambridge, Massachusetts, that focuses on developing plant-based feed production systems aimed at enhancing the sustainability of agriculture. Founded in 2019, FYTO specializes in creating nutrient-dense crops that require minimal resources, alongside cultivation and harvesting systems designed to ensure quality and consistency. The company's offerings include a variety of agricultural products such as animal feed, plant-based proteins, nutritional supplements, and bio-fertilizers. By adopting climate-friendly practices and methodologies, FYTO aims to support farmers globally in achieving improved economic and environmental outcomes in their agricultural operations.

Sesame, Inc., also known as SesameCare, is a New York-based company founded in 2018 that specializes in providing a platform for booking medical appointments and consultations. The company distinguishes itself by offering affordable healthcare options, enabling Americans to access quality medical services at significantly reduced prices compared to traditional providers. By utilizing an AI-enabled marketplace, Sesame eliminates the need for insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. Additionally, Sesame serves as the official telehealth partner of Costco, further enhancing its reach and service offerings in the healthcare sector.

Nava is a health insurance brokerage based in New York, New York, dedicated to providing high-quality, affordable healthcare solutions to employers and their employees. The company offers a range of services that include healthcare tools, year-round employee advocacy, and continuous evaluation of healthcare plans. By leveraging these resources, Nava empowers clients to deliver essential benefits while simultaneously reducing overall plan costs. Its innovative approach aims to transform the employee benefits landscape through enhanced access and advocacy in healthcare.

Strella Biotechnology, Inc. is a Philadelphia-based company that designs and manufactures sensor-based devices aimed at maximizing the freshness of produce throughout the supply chain. Founded in 2018 by Jacob Jordan and Katherine Sizov, the company specializes in ethylene detection technology, which assesses the ripeness of fruit by measuring the ethylene gas emitted during ripening. This innovation helps to optimize the produce supply chain by providing critical data that reduces spoilage and enhances the management of fresh produce. Strella Biotechnology leverages its patented technology to support efficiency and maintain quality in food distribution.

Invetx, Inc. is a biotechnology company focused on developing protein-based therapeutics for animal health care and veterinary medicine. Based in Boston, Massachusetts, Invetx's team comprises veterinary scientists and clinicians dedicated to discovering and creating biotherapeutics for both pets and farm animals. The company aims to enhance health outcomes in the animal health industry by leveraging biopharma technologies, supported by a network of experts in animal and human health. Through its innovative platform, Invetx is committed to advancing a portfolio of therapies and technologies designed to improve animal care and well-being.

Celsius Therapeutics is a biotechnology company focused on developing precision medicines for patients with cancer and autoimmune diseases. Founded in 2018 and based in Cambridge, Massachusetts, the company employs a team of scientists, technologists, computational biologists, clinicians, and drug hunters. Utilizing single-cell genomic analysis and machine learning techniques, Celsius Therapeutics aims to discover and create innovative therapies that can lead to significant improvements in patient outcomes. The company's research efforts are centered on identifying new drug candidates that address unmet medical needs in the therapeutic landscape.

LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.

Agolo, Inc. is a New York-based company that specializes in developing an artificial intelligence platform designed to create real-time summaries from unstructured information. Utilizing machine learning and natural language processing, Agolo's technology transforms messy data into a clean, structured format, enabling various enterprise applications such as business intelligence dashboards and support site augmentation. The platform helps organizations enhance their product quality, reduce support costs, and quickly identify emerging issues by providing clear insights into customer experiences. Established in 2012 and formerly known as Ninoh, Inc., Agolo serves a diverse range of industries, empowering professionals to efficiently analyze large volumes of data and make informed decisions based on comprehensive summaries.

Mandiant is a prominent provider of incident response and computer forensics solutions within the information security sector. Based in Alexandria, Virginia, the company operates additional offices in New York, Los Angeles, and San Francisco. Mandiant offers a range of products and professional services, including threat intelligence, automated response, and managed security, catering to a diverse clientele that includes Fortune 500 companies, financial institutions, government agencies, and law enforcement entities. With one of the largest teams dedicated to incident response and forensics, Mandiant is recognized for its expertise in mitigating cyber threats and enhancing organizational security measures. The company's consultants and engineers are highly qualified, holding advanced degrees and top government security clearances, and have authored numerous books on cybersecurity.

Dbt Labs is a developer of an open-source analytics engineering tool founded in 2016 and headquartered in Philadelphia, Pennsylvania. The company focuses on empowering data analysts to create and disseminate organizational knowledge through its innovative platform. By enabling users with SQL knowledge to build data transformation workflows, Dbt Labs provides a transformation workflow tool that facilitates quick and collaborative deployment of analytics code. This tool emphasizes software engineering practices such as modularity, portability, and documentation, thereby allowing teams to streamline their analytics processes and enhance their ability to derive insights from data.

RightHand Robotics, Inc. specializes in the manufacturing of robotic order-picking systems designed to enhance supply chain logistics and order fulfillment across various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015, the company is headquartered in Cambridge, Massachusetts, with an additional office in Frankfurt, Germany. RightHand Robotics offers innovative solutions like the ReFlex SF, which features a 3D-printed palm equipped with advanced servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that aids in gentle object handling. Their technology enables robots to automatically grasp a wide range of items from bins and cases without the need for extensive data entry or parameter tuning, making their systems cost-effective and adaptable to changing business needs.

Genesis Global Technology Limited specializes in developing custom software and solutions tailored for the capital markets. Founded in 2015 and headquartered in London, with an additional office in New York, the company provides a range of platforms designed to enhance trading and operational efficiency. Its offerings include an automated quoting system for managing requests for quotes, an order execution management system, and a trade allocation manager that facilitates various trading processes. Additionally, Genesis Global offers tools for data management and reconciliation, such as a short/long code manager and a matcher. The company is led by a team of industry veterans with substantial experience in trading technologies across multiple asset classes, aiming to deliver innovative solutions that align with the evolving needs of clients in the financial sector.

Scandit AG is a technology company specializing in barcode scanning software solutions and mobile computer vision. Founded in 2009 and headquartered in Zurich, Switzerland, with additional offices in the United States and Europe, Scandit develops applications that enable high-performance scanning on various smart devices, including smartphones, tablets, and wearables. Its offerings include the Barcode Scanner SDK, which transforms devices into enterprise-grade scanning tools, and the MatrixScan feature that enhances recognition processes for retail and logistics. Scandit's solutions are utilized across multiple industries, such as retail, healthcare, and manufacturing, to support applications like mobile shopping, inventory management, and asset tracking. The company's technology also incorporates augmented reality capabilities, providing real-time information overlays to improve user experience. Scandit aims to enhance operational efficiency and customer satisfaction for organizations, serving a diverse clientele that includes well-known brands.

Siemplify Ltd. is a provider of a comprehensive security operations platform designed to enhance the efficiency of security analysts and teams. Founded in 2015 and headquartered in New York, the company focuses on simplifying threat analysis and response through its advanced platform, which integrates security orchestration, automation, and contextual investigation. By utilizing profiling algorithms, the platform identifies and prioritizes critical alerts, while visualization techniques present threats as interactive storylines, streamlining the investigation process. Its graph analytics capabilities consolidate data from various internal and external sources, creating a cohesive view of security incidents. Siemplify's approach aims to reduce the complexity of security operations, enabling teams to react more swiftly to threats, ultimately fostering a culture of continuous improvement in security operations centers.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

Quartet Health is a New York-based company that develops a cloud-based platform designed to enhance communication and collaboration between medical providers and behavioral health providers for patient care. Founded in 2014, Quartet's platform works with health plans and systems to deliver actionable insights and reports on behavioral health conditions, aiming to improve patient outcomes. The platform also offers tools for patient self-management and ensures that mental health care is tailored to individual preferences and clinical needs, while being integrated with the broader healthcare experience and insurance coverage.

Mabl Inc. is an intelligent test automation company based in Boston, Massachusetts, founded in 2016. It offers an automated testing service that leverages machine learning to identify regressions and automatically fix broken tests. The platform provides scriptless testing and integrates seamlessly into the continuous integration and continuous deployment (CI/CD) development lifecycle, allowing software teams to create and maintain reliable, auto-healing tests. By streamlining the testing process, Mabl enables organizations to enhance the speed and quality of their software releases, facilitating faster delivery of high-quality applications while helping developers and testers address bugs before they reach production.

RightHand Robotics, Inc. specializes in the manufacturing of robotic order-picking systems designed to enhance supply chain logistics and order fulfillment across various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015, the company is headquartered in Cambridge, Massachusetts, with an additional office in Frankfurt, Germany. RightHand Robotics offers innovative solutions like the ReFlex SF, which features a 3D-printed palm equipped with advanced servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that aids in gentle object handling. Their technology enables robots to automatically grasp a wide range of items from bins and cases without the need for extensive data entry or parameter tuning, making their systems cost-effective and adaptable to changing business needs.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, the company utilizes the repeatome—a previously overlooked segment of genetic material—to create novel treatment options. By identifying multiple drug targets and advancing several discovery programs, ROME Therapeutics aims to tap into this unexplored area of biology. The organization has assembled a team of experts in oncology, immunology, virology, and machine learning to lead its research and development efforts, which are designed to provide healthcare professionals with effective new treatments for patients suffering from these conditions.

SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics, catering to global enterprises. Founded in 2011 and headquartered in San Francisco, California, the company offers the SingleStore Managed Service, a cloud database-as-a-service that enables analytics on various cloud platforms, alongside SingleStore DB, a distributed SQL database suitable for both bare metal and hybrid cloud environments. The company focuses on operational analytics and supports modern data platform solutions that encompass IoT analytics, risk management, and customer engagement. SingleStore serves a diverse range of industries, including financial services, media communications, energy and utilities, government, and retail. The company, previously known as MemSQL Inc., rebranded to SingleStore, Inc. in October 2020 and also maintains offices in Seattle, Boston, Portland, Lisbon, and London.

TMRW Life Sciences is a technology company focused on improving standards of safety, transparency, and accountability in the management of frozen eggs and embryos within the IVF sector. The company has developed the first automated cryo-management platform specifically designed for this purpose, which integrates a digital chain of custody with robotic storage and monitoring solutions. This innovative approach aims to replace traditional manual methods that have remained largely unchanged over the years, thereby significantly reducing the risk of errors that could have serious consequences. Founded in 2018 by Joshua Abram, Alan Murray, and Dr. Jeffrey Port, TMRW combines expertise in fertility, embryology, cryo-management, automation, software development, and robotics to enhance the specimen management process for clinics, facilitating advancements in IVF technology. The company is headquartered in New York, New York.

Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, focused on developing novel cancer therapies that target monoPARP proteins, which are essential regulators of cancer survival mechanisms. Established in 2015, Ribon is leveraging insights from its scientific founders and an experienced management team to create a proprietary drug discovery platform aimed at understanding the molecular actions and biological functions of monoPARPs. This platform enables the development of small molecule inhibitors designed to disrupt cancer cells' abilities to withstand stress, potentially leading to innovative treatments for cancer and other diseases. The company is supported by notable life science investors, positioning it for growth in the biopharmaceutical sector.

Merlin Labs is an innovative company focused on creating autonomous flight technology for advanced air travel, primarily utilizing fixed-wing aircraft. Founded in 2018 and headquartered in Boston, Massachusetts, the company develops a sophisticated aircraft autonomy system that employs artificial intelligence and machine learning, akin to the technology used in driverless cars. This system aims to facilitate the pilotless transportation of goods and eventually people, establishing a new infrastructure for aerial mobility.

Bowery Farming Inc. is a modern agricultural company based in New York, specializing in post-organic produce. Founded in 2014, the company focuses on growing a variety of greens, including baby kale, lettuce, arugula, and basil, using innovative indoor farming techniques. By leveraging advanced technology, such as its proprietary BoweryOS software, Bowery Farming creates optimal conditions for plant growth, allowing it to operate without pesticides and using significantly less water compared to traditional farming methods. This technology enables the company to be over 100 times more productive on the same land footprint. Bowery's products are distributed through grocery stores and featured in the menus of renowned restaurants, emphasizing the company's commitment to providing fresh, sustainable produce to consumers.

Overture Life, Inc. is a biotechnology company established in 2017 and headquartered in New York, New York. The company specializes in developing robotic technology and medical devices aimed at automating the in vitro fertilization (IVF) process. Overture Life's innovations include novel embryo testing methodologies and automated cryopreservation services, which help fertility clinics identify viable embryos prior to implantation. By streamlining the IVF process, Overture Life aims to make artificial insemination more accessible, reduce costs, optimize resource use, and improve success rates for practitioners and patients alike.

Dyno Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative adeno-associated virus (AAV) vectors for gene therapy applications. Founded in 2018, the company employs an artificial intelligence-powered platform that integrates next-generation DNA synthesis, high-throughput sequencing, and machine learning. This advanced approach allows Dyno Therapeutics to design and optimize cell-targeting capsids, which are crucial for the effective and safe delivery of gene therapies. By leveraging its technology, the company aims to provide medical researchers with novel AAV vectors that enhance the efficacy of in vivo therapeutic solutions.

Affinia Therapeutics Inc. is focused on developing gene therapies for various diseases, particularly those affecting the muscles and central nervous system. The company specializes in creating adeno-associated virus (AAV) vectors, leveraging advanced techniques in synthetic and systems biology, as well as high-throughput screening and tissue and single-cell resolution. Founded in 2019 and based in Waltham, Massachusetts, Affinia aims to address significant unmet medical needs by providing rationally designed gene therapies with improved properties. The company's innovative approach seeks to offer effective treatments for devastating conditions that currently lack adequate therapeutic options.

Treeline Biosciences is a biotechnology company established in 2021 and based in Stamford, Connecticut. The company focuses on developing transformative precision medicines aimed at treating cancer and other serious health conditions. Utilizing a comprehensive drug discovery platform, Treeline combines mechanistic biology, medicinal chemistry, computational science, structural biology, and protein science to create innovative therapeutic solutions. Through its research and development efforts, Treeline aims to provide effective treatments to improve patient outcomes in oncology and beyond.

Tend is a modern dental care provider that aims to transform the patient experience by offering personalized and hassle-free services. Launched in October 2019, the company has established 25 locations across major cities including New York, Washington DC, Boston, Atlanta, Nashville, and Connecticut. Tend focuses on patient happiness in a calm and inviting environment, leveraging technology and a hospitality-driven approach alongside a highly skilled clinical team. By prioritizing comfort and efficiency, Tend has become one of the top-rated full-service dental practices in the country, employing over 650 team members to support its mission of delivering quality oral health care.

SecurityScorecard, Inc., founded in 2013 by Dr. Alex Yampolskiy and Sam Kassoumeh, is a leading provider of cybersecurity ratings and continuous monitoring services. The company's platform assesses the cybersecurity strength of third-party vendors and businesses, offering solutions like ThreatMarket, a cloud-based vulnerability search engine, and Score Planner for remediation paths. SecurityScorecard serves Fortune 1000 organizations worldwide, providing tools for vendor risk management, board reporting, and cyber insurance underwriting. Its patented technology rates over a million companies continuously, enabling organizations to identify and mitigate cybersecurity risks across their digital footprint. The company is based in New York, New York.

Genesis Global Technology Limited specializes in developing custom software and solutions tailored for the capital markets. Founded in 2015 and headquartered in London, with an additional office in New York, the company provides a range of platforms designed to enhance trading and operational efficiency. Its offerings include an automated quoting system for managing requests for quotes, an order execution management system, and a trade allocation manager that facilitates various trading processes. Additionally, Genesis Global offers tools for data management and reconciliation, such as a short/long code manager and a matcher. The company is led by a team of industry veterans with substantial experience in trading technologies across multiple asset classes, aiming to deliver innovative solutions that align with the evolving needs of clients in the financial sector.

Snyk Ltd., established in 2015, specializes in a Software as a Service (SaaS) platform that enhances application security. It focuses on identifying, rectifying, and monitoring known vulnerabilities across critical components of modern applications, including code, open-source libraries, containers, and infrastructure as code. Snyk's offerings, such as Snyk Code (static application security testing), container vulnerability management, and application security management, integrate seamlessly with developers' workflows, improving security posture, productivity, and collaboration. With over 1,200 global customers, including industry leaders like Google and Salesforce, Snyk is recognized for its developer-first approach and strategic partnerships.

TScan Therapeutics is a biopharmaceutical company dedicated to discovering and developing innovative T cell receptor (TCR) engineered therapies to combat various cancers. Based in Waltham, Massachusetts, the company focuses on TCR-T therapies for both liquid cancers and solid tumors. Its lead candidates, TSC-100 and TSC-101, are designed to address hematologic malignancies, specifically targeting residual leukemia and preventing relapse after hematopoietic stem cell transplantation. In addition, TScan is advancing a multiplexed TCR-T therapy program aimed at treating a range of solid tumors. The company's proprietary platform identifies clinically relevant T cell antigens and minimizes off-target effects, enhancing the precision of its therapies. Founded in 2018, TScan Therapeutics is committed to improving outcomes for patients with serious diseases.

Verve Therapeutics, Inc. is a genetic medicines company focused on innovative treatments for cardiovascular disease through gene editing. Founded in 2018 and based in Cambridge, Massachusetts, with a research facility in Philadelphia, the company aims to shift the management of cardiovascular conditions from chronic treatments to single-course gene editing therapies. Its initial programs concentrate on the PCSK9 and ANGPTL3 genes, which are known to significantly impact blood lipid levels, a major factor in cardiovascular disease. Verve Therapeutics collaborates with partners such as Beam Therapeutics and Verily to enhance its gene editing delivery technologies. The company is staffed by a team of experts in cardiovascular medicine, human genetics, and drug development, positioning itself to address the challenges of cardiovascular health effectively.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on transforming the drug discovery and delivery process to address the rising costs of medicines. Founded in 2019, EQRx aims to provide a market-based solution by leveraging advances in science and technology while collaborating with various healthcare stakeholders. The company has over ten programs in its pipeline targeting oncology and immune-inflammatory conditions, which include clinical and preclinical stages, as well as drug engineering initiatives. Among its key programs are Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab. Through its innovative approach, EQRx seeks to develop high-quality, patent-protected medicines more efficiently and cost-effectively than traditional pharmaceutical methods.

LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.

SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics, catering to global enterprises. Founded in 2011 and headquartered in San Francisco, California, the company offers the SingleStore Managed Service, a cloud database-as-a-service that enables analytics on various cloud platforms, alongside SingleStore DB, a distributed SQL database suitable for both bare metal and hybrid cloud environments. The company focuses on operational analytics and supports modern data platform solutions that encompass IoT analytics, risk management, and customer engagement. SingleStore serves a diverse range of industries, including financial services, media communications, energy and utilities, government, and retail. The company, previously known as MemSQL Inc., rebranded to SingleStore, Inc. in October 2020 and also maintains offices in Seattle, Boston, Portland, Lisbon, and London.

Hodinkee is a New York-based company established in 2008, operating an online magazine dedicated to reviewing, critiquing, and reporting on watches. It also runs pop-up shops and an e-boutique for selling vintage watches, straps, menswear accessories like watch pockets and travel rolls, and luxury goods such as wristwatches, knit ties, pocket squares, and travel pouches. Hodinkee's platform offers a trusted retail outlet, HODINKEE Shop, alongside industry news, creative storytelling, a podcast, and a bi-annual publication, aiming to provide an approachable, authentic, and honest experience for luxury product enthusiasts.

Superplastic, Inc. is a character-based product and entertainment company founded in 2017 and based in Burlington, Vermont. The company specializes in manufacturing and marketing limited edition art toys, apparel, games, and animation, featuring unique characters created in collaboration with renowned artists. Superplastic leverages the principles of effort and scarcity to enhance the value of its offerings, creating exclusive works of art for a select audience. The company also operates a platform that engages customers through various media, including animated videos and music, enabling interactions with its synthetic superstars in innovative ways. Products are primarily sold online, reflecting a modern approach to retail and entertainment.

Tend is a modern dental care provider that aims to transform the patient experience by offering personalized and hassle-free services. Launched in October 2019, the company has established 25 locations across major cities including New York, Washington DC, Boston, Atlanta, Nashville, and Connecticut. Tend focuses on patient happiness in a calm and inviting environment, leveraging technology and a hospitality-driven approach alongside a highly skilled clinical team. By prioritizing comfort and efficiency, Tend has become one of the top-rated full-service dental practices in the country, employing over 650 team members to support its mission of delivering quality oral health care.

Our first app, HAGS: Yearbook Signatures, let let tens of thousands of students sign their yearbooks through Snapchat. HAGS will be relaunching as an entirely new space for high school students to interact with their class. Based in New York.

UJET, Inc. specializes in developing customer support software and platform solutions that enhance customer communications. Founded in 2015 and headquartered in San Francisco, with additional offices in New York and Seoul, the company offers a cloud contact center platform that integrates seamlessly with major customer relationship management systems like Salesforce, Zendesk, and Kustomer. UJET's platform is designed for the smartphone era, modernizing digital and in-app customer experiences while eliminating the need for customers to switch between different communication channels. By utilizing multiple voices, online messaging, and mobile features, UJET assists customer service agents in managing incoming calls and resolving issues efficiently. The incorporation of artificial intelligence across its services further automates processes and improves interaction quality. Additionally, UJET provides a wait time messaging tool that offers live updates to customers while they are on hold, enhancing overall service satisfaction.

Sana Biotechnology, Inc. is a biotechnology company focused on developing engineered cells as therapies to treat a wide range of diseases. Established in 2018 and headquartered in Seattle, Washington, with additional offices in South San Francisco and Cambridge, the company utilizes advanced scientific techniques to reprogram cells or replace damaged cells and tissues. This innovative approach aims to create a new class of medicines that address unmet treatment needs across various therapeutic areas, including oncology, diabetes, autoimmune disorders, and central nervous system conditions. Sana's pipeline includes several product candidates designed to provide meaningful medical solutions and transform disease treatment methodologies.

Verve Therapeutics, Inc. is a genetic medicines company focused on innovative treatments for cardiovascular disease through gene editing. Founded in 2018 and based in Cambridge, Massachusetts, with a research facility in Philadelphia, the company aims to shift the management of cardiovascular conditions from chronic treatments to single-course gene editing therapies. Its initial programs concentrate on the PCSK9 and ANGPTL3 genes, which are known to significantly impact blood lipid levels, a major factor in cardiovascular disease. Verve Therapeutics collaborates with partners such as Beam Therapeutics and Verily to enhance its gene editing delivery technologies. The company is staffed by a team of experts in cardiovascular medicine, human genetics, and drug development, positioning itself to address the challenges of cardiovascular health effectively.

PatientPing, Inc. is a health technology company that has established a national care coordination network designed to connect healthcare providers with real-time notifications whenever patients receive care. The network encompasses a diverse group of healthcare personnel, including physicians, nurses, case managers, and care coordinators across various settings such as hospitals, emergency departments, and skilled nursing facilities. PatientPing offers technology solutions tailored to Accountable Care Organizations (ACOs) and other healthcare providers, facilitating improved collaboration and information sharing. One of its key tools, Spotlights, leverages real-time data to identify utilization and performance trends in patient care. Founded in 2013 and headquartered in Boston, Massachusetts, PatientPing operates as a subsidiary of SVB Leerink Holdings LLC and maintains a strategic partnership with MedAllies, Inc. By fostering connections among care teams, PatientPing aims to enhance the quality and efficiency of healthcare delivery, ultimately leading to better patient outcomes.

Scandit AG is a technology company specializing in barcode scanning software solutions and mobile computer vision. Founded in 2009 and headquartered in Zurich, Switzerland, with additional offices in the United States and Europe, Scandit develops applications that enable high-performance scanning on various smart devices, including smartphones, tablets, and wearables. Its offerings include the Barcode Scanner SDK, which transforms devices into enterprise-grade scanning tools, and the MatrixScan feature that enhances recognition processes for retail and logistics. Scandit's solutions are utilized across multiple industries, such as retail, healthcare, and manufacturing, to support applications like mobile shopping, inventory management, and asset tracking. The company's technology also incorporates augmented reality capabilities, providing real-time information overlays to improve user experience. Scandit aims to enhance operational efficiency and customer satisfaction for organizations, serving a diverse clientele that includes well-known brands.

Owkin, Inc. is an artificial intelligence company that specializes in developing software aimed at improving treatment outcomes for patients, particularly in oncology. Established in 2016, with headquarters in New York and an office in Paris, Owkin employs AI tools to enhance drug discovery and accelerate clinical trials while safeguarding patient privacy through federated learning. The company offers several products, including Owkin Lab for therapeutic data connection, Owkin Loop for validated and packaged models, and a comprehensive software stack. Owkin's portfolio includes 30 live models, with an additional 40 in development, focusing on identifying new drug candidates and elucidating the mechanisms behind treatment efficacy. Co-founded by Thomas Clozel, a clinical research doctor, and Gilles Wainrib, a machine learning expert, Owkin has raised over $255 million and achieved unicorn status due to its innovative approach in addressing unmet medical needs and optimizing the drug development process.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, the company utilizes the repeatome—a previously overlooked segment of genetic material—to create novel treatment options. By identifying multiple drug targets and advancing several discovery programs, ROME Therapeutics aims to tap into this unexplored area of biology. The organization has assembled a team of experts in oncology, immunology, virology, and machine learning to lead its research and development efforts, which are designed to provide healthcare professionals with effective new treatments for patients suffering from these conditions.

Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom, the company utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, using a repository of over 15,000 human brain tissue samples. This platform provides detailed expression and epigenetic data, allowing Cerevance to identify promising therapeutic targets for central nervous system diseases. Through its research, the company aims to advance new medicines that can potentially address the underlying mechanisms of these debilitating conditions.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on transforming the drug discovery and delivery process to address the rising costs of medicines. Founded in 2019, EQRx aims to provide a market-based solution by leveraging advances in science and technology while collaborating with various healthcare stakeholders. The company has over ten programs in its pipeline targeting oncology and immune-inflammatory conditions, which include clinical and preclinical stages, as well as drug engineering initiatives. Among its key programs are Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab. Through its innovative approach, EQRx seeks to develop high-quality, patent-protected medicines more efficiently and cost-effectively than traditional pharmaceutical methods.

TScan Therapeutics is a biopharmaceutical company dedicated to discovering and developing innovative T cell receptor (TCR) engineered therapies to combat various cancers. Based in Waltham, Massachusetts, the company focuses on TCR-T therapies for both liquid cancers and solid tumors. Its lead candidates, TSC-100 and TSC-101, are designed to address hematologic malignancies, specifically targeting residual leukemia and preventing relapse after hematopoietic stem cell transplantation. In addition, TScan is advancing a multiplexed TCR-T therapy program aimed at treating a range of solid tumors. The company's proprietary platform identifies clinically relevant T cell antigens and minimizes off-target effects, enhancing the precision of its therapies. Founded in 2018, TScan Therapeutics is committed to improving outcomes for patients with serious diseases.

Kitchen United, Inc. is a food production company based in Pasadena, California, founded in 2017. It specializes in offering shared commercial kitchen spaces designed for restaurants, catering services, pop-ups, mobile food vendors, and startups. By providing turnkey solutions and business intelligence resources, Kitchen United enables food service providers to expand their operations with minimal financial risk. The company facilitates food production for pick-up and delivery, catering to the growing demand for convenient dining options. Kitchen United operates multiple locations across major cities, including Austin, Chicago, Los Angeles, San Francisco, New York City, and Scottsdale, thereby supporting a diverse range of culinary entrepreneurs in realizing their business potential.

Snyk Ltd., established in 2015, specializes in a Software as a Service (SaaS) platform that enhances application security. It focuses on identifying, rectifying, and monitoring known vulnerabilities across critical components of modern applications, including code, open-source libraries, containers, and infrastructure as code. Snyk's offerings, such as Snyk Code (static application security testing), container vulnerability management, and application security management, integrate seamlessly with developers' workflows, improving security posture, productivity, and collaboration. With over 1,200 global customers, including industry leaders like Google and Salesforce, Snyk is recognized for its developer-first approach and strategic partnerships.

Socratic, Inc. is an education technology company that specializes in developing a homework assistance application for students. Founded in 2013 and based in New York, the company utilizes artificial intelligence to provide users with answers, detailed explanations, and curated educational content across a variety of subjects, including math, science, history, English, and economics. The app allows students to take photos of their homework questions, making it accessible and user-friendly. It features graphs, explainers, and links to instructional videos from platforms such as Khan Academy, enhancing the learning experience. Socratic is available for free on both iPhone and Android devices, focusing primarily on high school curriculum support. The company, formerly known as Vespr, Inc., rebranded to Socratic, Inc. in May 2015.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

Agolo, Inc. is a New York-based company that specializes in developing an artificial intelligence platform designed to create real-time summaries from unstructured information. Utilizing machine learning and natural language processing, Agolo's technology transforms messy data into a clean, structured format, enabling various enterprise applications such as business intelligence dashboards and support site augmentation. The platform helps organizations enhance their product quality, reduce support costs, and quickly identify emerging issues by providing clear insights into customer experiences. Established in 2012 and formerly known as Ninoh, Inc., Agolo serves a diverse range of industries, empowering professionals to efficiently analyze large volumes of data and make informed decisions based on comprehensive summaries.

TScan Therapeutics is a biopharmaceutical company dedicated to discovering and developing innovative T cell receptor (TCR) engineered therapies to combat various cancers. Based in Waltham, Massachusetts, the company focuses on TCR-T therapies for both liquid cancers and solid tumors. Its lead candidates, TSC-100 and TSC-101, are designed to address hematologic malignancies, specifically targeting residual leukemia and preventing relapse after hematopoietic stem cell transplantation. In addition, TScan is advancing a multiplexed TCR-T therapy program aimed at treating a range of solid tumors. The company's proprietary platform identifies clinically relevant T cell antigens and minimizes off-target effects, enhancing the precision of its therapies. Founded in 2018, TScan Therapeutics is committed to improving outcomes for patients with serious diseases.

Quartet Health is a New York-based company that develops a cloud-based platform designed to enhance communication and collaboration between medical providers and behavioral health providers for patient care. Founded in 2014, Quartet's platform works with health plans and systems to deliver actionable insights and reports on behavioral health conditions, aiming to improve patient outcomes. The platform also offers tools for patient self-management and ensures that mental health care is tailored to individual preferences and clinical needs, while being integrated with the broader healthcare experience and insurance coverage.

Yellowbrick Learning, Inc. is an online platform that specializes in creating tailored learning experiences for individuals seeking to explore and advance their careers in creative industries such as fashion, sports, beauty, music, and media. Established in 2013 and headquartered in New York, the company collaborates with prominent universities, brands, and industry leaders to provide educational services that align with students' talents and passions. By offering carefully designed assignments and insights, Yellowbrick enables students to acquire relevant skills and navigate their career paths more effectively, thereby empowering the next generation of talent in the creative arts and entertainment sectors.

Iridescent's mission is to create and deliver powerful science, engineering, and technology education to help underprivileged children develop curiosity, creativity, and persistence. Iridescent runs in-person programs at our science studios in south LA and the south Bronx, including our Family Science programs, which connect engineering students with under-served students and their families through hands-on engineering design challenges. All of these challenges are also available online, through our online learning platform The Curiosity Machine, where students are virtually mentored by STEM professionals with every design they submit. Iridescent also runs the Technovation Challenge, the largest global technology entrepreneurship program for young women.

Verve Therapeutics, Inc. is a genetic medicines company focused on innovative treatments for cardiovascular disease through gene editing. Founded in 2018 and based in Cambridge, Massachusetts, with a research facility in Philadelphia, the company aims to shift the management of cardiovascular conditions from chronic treatments to single-course gene editing therapies. Its initial programs concentrate on the PCSK9 and ANGPTL3 genes, which are known to significantly impact blood lipid levels, a major factor in cardiovascular disease. Verve Therapeutics collaborates with partners such as Beam Therapeutics and Verily to enhance its gene editing delivery technologies. The company is staffed by a team of experts in cardiovascular medicine, human genetics, and drug development, positioning itself to address the challenges of cardiovascular health effectively.

Arrakis Therapeutics, Inc. is a biopharmaceutical company focused on developing a proprietary platform for drug discovery that targets ribonucleic acid (RNA). The company aims to identify new RNA targets and create small-molecule drug candidates, primarily addressing cancer and other genetically validated diseases. Its innovative platform combines advanced RNA bioinformatics, structural tools, chemical biology, and medicinal chemistry, facilitating the development of RNA-targeted small molecules (rSMs). Additionally, Arrakis offers SHAPEware, a software tool designed to predict RNA secondary structures and potential ligand-binding sites. Founded in 2015, Arrakis Therapeutics is headquartered in Waltham, Massachusetts, and its work enables improved treatment options for various conditions, including neurological disorders and rare genetic diseases.

Lemonade, Inc. is an innovative insurance company that provides a range of insurance products in the United States and Europe, including homeowners, renters, and landlord insurance. Founded in 2015 and headquartered in New York, the company utilizes artificial intelligence and behavioral economics to streamline the insurance process, eliminating traditional brokers and paperwork. By employing advanced technology, Lemonade offers instant service and sets competitive rates for its policies. The company also acts as an agent for other insurance providers, further expanding its offerings. With a commitment to social good, Lemonade aims to transform the insurance industry by prioritizing transparency and efficiency.

Lola Travel Company, Inc. specializes in corporate travel management through its AI-driven platform, Lola.com. Established in 2015 and headquartered in Boston, Massachusetts, the company simplifies the travel booking process for businesses by offering an intuitive tool for flight and hotel reservations. Lola.com allows users to manage itineraries via a mobile application, providing individual travel profiles, digital travel receipts, and budget tracking services. The platform also supports employee-friendly travel policies, efficient spend reporting for managers, and features that enable team destination sharing and loyalty point accumulation. With 24/7 agent assistance and capabilities for executive assistants to book travel on behalf of others, Lola.com caters to the needs of both employers and business travelers, streamlining the overall travel experience.

Owkin, Inc. is an artificial intelligence company that specializes in developing software aimed at improving treatment outcomes for patients, particularly in oncology. Established in 2016, with headquarters in New York and an office in Paris, Owkin employs AI tools to enhance drug discovery and accelerate clinical trials while safeguarding patient privacy through federated learning. The company offers several products, including Owkin Lab for therapeutic data connection, Owkin Loop for validated and packaged models, and a comprehensive software stack. Owkin's portfolio includes 30 live models, with an additional 40 in development, focusing on identifying new drug candidates and elucidating the mechanisms behind treatment efficacy. Co-founded by Thomas Clozel, a clinical research doctor, and Gilles Wainrib, a machine learning expert, Owkin has raised over $255 million and achieved unicorn status due to its innovative approach in addressing unmet medical needs and optimizing the drug development process.

Beam Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, specializing in the development of precision genetic medicines utilizing its innovative base editing technology. Founded in 2017, the company aims to provide lifelong cures for patients suffering from serious diseases by targeting specific bases in the genome without inducing double-stranded breaks in DNA. Beam Therapeutics is actively developing therapies for a range of conditions, including sickle cell disease, beta-thalassemia, pediatric T-cell acute lymphoblastic leukemia, pediatric acute myeloid leukemia, alpha-1 antitrypsin deficiency, glycogen storage disorder type 1A, as well as ocular and central nervous system disorders. The company’s diverse pipeline includes several programs such as BEAM-101, BEAM-201, BEAM-301, BEAM-302, and ESCAPE, reflecting its commitment to advancing gene correction, gene modification, gene activation, gene silencing, and multiplex editing technologies.

CTRL-Labs Corporation, founded in 2015 and based in New York City, specializes in developing non-invasive neural interface technology aimed at enhancing the interaction between humans and machines. The company's flagship product, the CTRL-kit, is a wireless wristband equipped with sensors that captures neural signals, allowing users to control digital devices through simple electronic pulses. This innovative platform is designed to support various applications in virtual reality, augmented reality, robotics, productivity, and clinical research. By providing developers with a software development kit (SDK) and application programming interface (API), CTRL-Labs enables the integration of neural control into their applications. The company's long-term vision focuses on fostering mass consumer adoption of neural interfaces, establishing a new standard for human-machine collaboration that transforms how users engage with technology.

2nd Address, Inc. operates an online marketplace that facilitates the booking and listing of furnished apartments, homes, and condominiums for both short-term and long-term rentals. Founded in 2014 and based in San Francisco, the company provides a platform that simplifies the leasing process for tenants and landlords in major urban markets across the United States, including cities like Washington, D.C., San Francisco, New York, and Chicago. The platform caters to a range of customers, from large corporations such as Google and Microsoft to smaller businesses, by offering a diverse selection of properties and flexible leasing options. Formerly known as HomeSuite, Inc., the company rebranded in November 2017 to enhance its identity in the marketplace.

Managed by Q Inc. is a workplace management platform headquartered in New York, New York, that streamlines the operation of office environments. Founded in 2013, the company provides a comprehensive range of services, including on-demand cleaning, maintenance, IT support, and security. Its technology platform serves as an all-in-one solution for businesses, connecting them to essential services such as supply replenishment, task management, and project management, which encompasses pre-lease planning, vendor management, office design, and renovations. By facilitating seamless office operations, Managed by Q aims to save time and resources for businesses while promoting economic empowerment through job creation and support for small businesses. The company operates in key markets, including New York, Los Angeles, Chicago, and San Francisco.

Relay Therapeutics, Inc. is a clinical-stage precision medicine company based in Cambridge, Massachusetts, focused on transforming the drug discovery process. The company employs a novel allosteric drug-discovery platform, known as Dynamo, which integrates advanced computational techniques with experimental methods to study protein motion and interactions. This innovative approach enables the identification and development of therapies targeting complex diseases, particularly in oncology. Relay Therapeutics is advancing a pipeline of product candidates, including RLY-1971, a small molecule inhibitor targeting SHP2, RLY-4008, a selective inhibitor of FGFR2 for advanced solid tumors, and RLY-PI3K1047, aimed at mutant variants of phosphoinositide 3-kinase alpha. Founded in 2015, the company aims to deliver life-changing therapies to patients by addressing previously intractable targets in precision oncology and genetic diseases.

RightHand Robotics, Inc. specializes in the manufacturing of robotic order-picking systems designed to enhance supply chain logistics and order fulfillment across various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015, the company is headquartered in Cambridge, Massachusetts, with an additional office in Frankfurt, Germany. RightHand Robotics offers innovative solutions like the ReFlex SF, which features a 3D-printed palm equipped with advanced servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that aids in gentle object handling. Their technology enables robots to automatically grasp a wide range of items from bins and cases without the need for extensive data entry or parameter tuning, making their systems cost-effective and adaptable to changing business needs.

Bowery Farming Inc. is a modern agricultural company based in New York, specializing in post-organic produce. Founded in 2014, the company focuses on growing a variety of greens, including baby kale, lettuce, arugula, and basil, using innovative indoor farming techniques. By leveraging advanced technology, such as its proprietary BoweryOS software, Bowery Farming creates optimal conditions for plant growth, allowing it to operate without pesticides and using significantly less water compared to traditional farming methods. This technology enables the company to be over 100 times more productive on the same land footprint. Bowery's products are distributed through grocery stores and featured in the menus of renowned restaurants, emphasizing the company's commitment to providing fresh, sustainable produce to consumers.

Kitchen United, Inc. is a food production company based in Pasadena, California, founded in 2017. It specializes in offering shared commercial kitchen spaces designed for restaurants, catering services, pop-ups, mobile food vendors, and startups. By providing turnkey solutions and business intelligence resources, Kitchen United enables food service providers to expand their operations with minimal financial risk. The company facilitates food production for pick-up and delivery, catering to the growing demand for convenient dining options. Kitchen United operates multiple locations across major cities, including Austin, Chicago, Los Angeles, San Francisco, New York City, and Scottsdale, thereby supporting a diverse range of culinary entrepreneurs in realizing their business potential.

Snyk Ltd., established in 2015, specializes in a Software as a Service (SaaS) platform that enhances application security. It focuses on identifying, rectifying, and monitoring known vulnerabilities across critical components of modern applications, including code, open-source libraries, containers, and infrastructure as code. Snyk's offerings, such as Snyk Code (static application security testing), container vulnerability management, and application security management, integrate seamlessly with developers' workflows, improving security posture, productivity, and collaboration. With over 1,200 global customers, including industry leaders like Google and Salesforce, Snyk is recognized for its developer-first approach and strategic partnerships.

Mabl Inc. is an intelligent test automation company based in Boston, Massachusetts, founded in 2016. It offers an automated testing service that leverages machine learning to identify regressions and automatically fix broken tests. The platform provides scriptless testing and integrates seamlessly into the continuous integration and continuous deployment (CI/CD) development lifecycle, allowing software teams to create and maintain reliable, auto-healing tests. By streamlining the testing process, Mabl enables organizations to enhance the speed and quality of their software releases, facilitating faster delivery of high-quality applications while helping developers and testers address bugs before they reach production.